154 related articles for article (PubMed ID: 8252482)
1. The uses and limitations of DNA flow cytometry in stage IB or II cervical carcinoma.
Lai CH; Hsueh S; Huang MY; Chang MF; Soong YK
Cancer; 1993 Dec; 72(12):3655-62. PubMed ID: 8252482
[TBL] [Abstract][Full Text] [Related]
2. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
[TBL] [Abstract][Full Text] [Related]
3. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
[TBL] [Abstract][Full Text] [Related]
4. Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.
Zanetta GM; Katzmann JA; Keeney GL; Kinney WK; Cha SS; Podratz KC
Gynecol Oncol; 1992 Jul; 46(1):13-9. PubMed ID: 1634134
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
7. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
Lutgens LC; Schutte B; de Jong JM; Thunnissen FB
Gynecol Oncol; 1994 Sep; 54(3):275-81. PubMed ID: 8088604
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
[TBL] [Abstract][Full Text] [Related]
9. DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b.
Horn LC; Raptis G; Nenning H
Anal Quant Cytol Histol; 2002 Feb; 24(1):23-9. PubMed ID: 11865946
[TBL] [Abstract][Full Text] [Related]
10. [The study of DNA ploidy as a prognostic factor in uterine cervical cancer].
Watanabe Y; Ikeda M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1127-34. PubMed ID: 1453042
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases.
Lai CH; Chang HC; Chang TC; Hsueh S; Tang SG
Gynecol Oncol; 1993 Dec; 51(3):390-6. PubMed ID: 7509304
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of preoperative DNA flow cytometry in surgically-treated cervical cancer.
Reich O; Pürstner P; Klaritsch P; Haas J; Lahousen M; Tamussino K; Winter R
Eur J Gynaecol Oncol; 2003; 24(1):13-7. PubMed ID: 12691309
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix.
Kenter GG; Cornelisse CJ; Aartsen EJ; Mooy W; Hermans J; Heintz AP; Fleuren GJ
Gynecol Oncol; 1990 Nov; 39(2):181-5. PubMed ID: 2227593
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of DNA cytometry in carcinoma of the uterine cervix FIGO stage IB and II.
Grote HJ; Friedrichs N; Pomjanski N; Guhde HF; Reich O; Böcking A
Anal Cell Pathol; 2001; 23(3-4):97-105. PubMed ID: 12082291
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of DNA ploidy and S-phase fraction of Stage IIIB cervical carcinoma.
Wilailak S; Rochanawutanon M; Srisupundit S; Aumkhyan A; Pattanapanyasat K
Eur J Gynaecol Oncol; 2004; 25(4):428-30. PubMed ID: 15285296
[TBL] [Abstract][Full Text] [Related]
17. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
18. Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran.
Behtash N; Karimi Zarchi M; Deldar M
Asian Pac J Cancer Prev; 2009; 10(4):613-8. PubMed ID: 19827880
[TBL] [Abstract][Full Text] [Related]
19. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
20. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]